ReviewFrontiers in oncology2019

Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer: Insights to Sequencing Treatment and Overcoming Resistance Based on Clinical Trials.

Rola El Sayed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.